Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A pseudogene is a DNA sequence that resembles a protein-coding gene but typically contains mutations, insertions, deletions, or lacks regulatory sequences, rendering it nonfunctional in terms of protein production[3][2][4]. The gene locus ENSG00000235113, labeled as "part of a novel pseudogene," likely represents a partial sequence region with homology to a functional gene but without a defined structure or biological activity[5][4]. Unlike functional genes, pseudogenes are characterized by loss of function and are not considered molecular targets for therapeutics, though in rare cases, some may produce regulatory RNAs or truncated peptides and influence disease processes[1][3][4][6]. The use of "part of a novel pseudogene" is problematic and not aligned with standard gene nomenclature guidelines[2][5], and no evidence exists that this pseudogene codes for a receptor, enzyme, transcription factor, or other known therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Part of a novel pseudogene (ENSG00000235113).